Bio Impact Capital LLC Y M Abs Therapeutics, Inc. Transaction History

Bio Impact Capital LLC

  • $641 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$6.55 - $17.42 $18,045 - $47,992
-2,755 Reduced 0.62%
443,702 $5.27 Million
Q4 2021

Feb 11, 2022
SELL
$15.51 - $29.31 $101,016 - $190,896
-6,513 Reduced 1.44%
446,457 $7.24 Million
Q3 2021

Nov 15, 2021
BUY
$27.47 - $37.31 $3.18 Million - $4.32 Million
115,679 Added 34.3%
452,970 $12.9 Million
Q4 2019

Feb 14, 2020
BUY
$23.81 - $33.78 $8.03 Million - $11.4 Million
337,291 New
337,291 $10.5 Million

Others Institutions Holding YMAB

# of Institutions
106
Shares Held
24.5M
Call Options Held
40.3K
Put Options Held
400
View Full List

About Y-mAbs Therapeutics, Inc.

YMAB Quotes by TradingView
  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $356M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email